Minerva Neurosciences Inc (NERV) — Capital Reinvestment Ratio

Latest as of December 2017: 0.02x

Minerva Neurosciences Inc (NERV) has a Capital Reinvestment Ratio of 0.02x as of December 2017, meaning it reinvests 0% of its operating cash flow ($3.09 Million) in capital expenditures ($52.40K). See Minerva Neurosciences Inc balance sheet quality to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.02x
Capex / Operating Cash Flow

Operating Cash Flow

$3.09 Million
USD

Capital Expenditures

$52.40K
USD

Data as of

Dec 2017
Most recent filing

Minerva Neurosciences Inc Capital Reinvestment Ratio (2017–2017)

This chart tracks Minerva Neurosciences Inc's Capital Reinvestment Ratio across 1 annual periods. Check Minerva Neurosciences Inc investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for Minerva Neurosciences Inc (2017–2017)

Year-by-year Capital Reinvestment Ratio for Minerva Neurosciences Inc from 2017 to 2017. For live market cap and broader valuation context, see market value of Minerva Neurosciences Inc.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2017 0.02x $3.09 Million $52.40K
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow